Glutamate-induced hypothalamic analgesia was mediated exclusively by arginine vasopressin signaling, with neither oxytocin nor opioid peptides contributing — further establishing vasopressin's dominant role in hypothalamic pain control.
Key findingMSG-induced hypothalamic analgesia was mediated through central AVP signaling exclusively, with oxytocin and opioid peptide antagonists having no effe
What the researchers found
MSG-induced hypothalamic analgesia was mediated through central AVP signaling exclusively, with oxytocin and opioid peptide antagonists having no effect — confirming vasopressin's dominance in hypothalamic pain modulation pathways.
Why it matters
Relevant for oxytocin, opioid-peptides, neuropeptides, pain.
How the study worked
animal-study study on oxytocin, opioid-peptides.
What this study cannot tell us
See abstract.
How to read the evidence
preliminary evidence.
When this study was published
Published in 2006.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Through central arginine vasopressin, not oxytocin and endogenous opiate peptides, glutamate sodium induces hypothalamic paraventricular nucleus enhancing acupuncture analgesia in the rat.
Neuroscience research, 54(1), 49-56
Citation
Yang, Jun; Liu, Wen-Yan; Song, Cao-You; Lin, Bao-Cheng. (2006). Through central arginine vasopressin, not oxytocin and endogenous opiate peptides, glutamate sodium induces hypothalamic paraventricular nucleus enhancing acupuncture analgesia in the rat.. Neuroscience research, 54(1), 49-56.